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The pharmacological treatment of obesity still faces many
barriers. Notably, these include the disregard of obesity as a
disease and the very limited treatment options for obesity. In
this context, this special issue is of special importance as it
focuses on several topics, related to this challenge.
After careful screening, review, and revision, we selected
26 articles which deal with a variety of aspects related to the
pharmacological therapy of obesity. Topics covered include
possible etiologies of the disease (e.g., A. Niijima’s rat study
and B. Bjorndal et al.’s research on adipogenesis), the role
of diet as an anti-inﬂammatory mediator (studies of B.
Sears and C. Ricordi and W. R. Hamilton et al.), some new
aspects of the drugs being used today, particularly orlistat
( A .H o l l y w o o da n dJ .O g d e n ,J .M a r t i ne ta l . ,a n dN .J .
Perera et al. studies), and outlining the treatment of special
conditions such as in children and adolescents (L. Iughett et
al.),polycysticovarysyndrome(H.Kahaletal.),anddiabetes
mellitus (V. Cheng and S. R. Kashyap). Additional reports
include reviews on the pharmacological treatment of obesity
in the present and future (M. Glandt and I. Raz and L. L.
Ioannides-Demos et al.).
To conclude, this edition of the journal describing ad-
vances in the pharmacological treatment of obesity will pro-
videthoseintheﬁeldwithnewandusefulinsightsonobesity
pathogenesis and management.
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